3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
2
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Rectal Neoplasms
1
Polyps
1
Neoplastic Syndromes, Hereditary
1
Neoplasms, Germ Cell and Embryonal
1
Medulloblastoma
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Hepatoblastoma
1
Genetic Diseases, Inborn
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Esophageal Neoplasms
1
Duodenal Neoplasms
1
Digestive System Neoplasms
1
Digestive System Diseases
1
Colonic Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Renal Cell
1
Brain Neoplasms
1
Barrett Esophagus
1
Adenomatous Polyps
1
Adenomatous Polyposis Coli
1
Adenoma
1
Interventions
Colonoscopy
4
Endoscopy
3
Eicosapentaenoic Acid
2
Uterine Myomectomy
1
Ursodeoxycholic Acid
1
Telemedicine
1
Suppositories
1
Sennosides
1
Restraint, Physical
1
Propofol
1
Narrow Band Imaging
1
Midazolam
1
Metoclopramide
1
Folic Acid
1
Fentanyl
1
Erythromycin
1
Diet, Fat-Restricted
1
Diet
1
Diatrizoate Meglumine
1
Colonography, Computed Tomographic
1
Clinical Chemistry Tests
1
Cholecystectomy
1
Cholecalciferol
1
Celecoxib
1
Calcium Carbonate
1
CVD protocol
1
Bisacodyl
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Polyps
×
Ursodeoxycholic Acid
×
Clear all
NCT00808743
2013-05-16
PreDuoFAP
Radboud University Medical Center
Phase 2/3
Completed
37 enrolled